Cargando…
Stem cell therapy on skin: Mechanisms, recent advances and drug reviewing issues
Stem cell products and its clinical applications have been widely discussed in recent years, particularly when the Japanese “induced pluripotent stem cells” founder Dr. Yamanaka was awarded as Nobel Prize laureate in 2013. For decades, major progresses have been achieved in the stem cell biology fie...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taiwan Food and Drug Administration
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9332639/ https://www.ncbi.nlm.nih.gov/pubmed/29389549 http://dx.doi.org/10.1016/j.jfda.2017.10.004 |
_version_ | 1784758697248948224 |
---|---|
author | Chu, Gong-Yau Chen, Yu-Fu Chen, Hsiao-Yun Chan, Ming-Hsiao Gau, Churn-Shiouh Weng, Shih-Ming |
author_facet | Chu, Gong-Yau Chen, Yu-Fu Chen, Hsiao-Yun Chan, Ming-Hsiao Gau, Churn-Shiouh Weng, Shih-Ming |
author_sort | Chu, Gong-Yau |
collection | PubMed |
description | Stem cell products and its clinical applications have been widely discussed in recent years, particularly when the Japanese “induced pluripotent stem cells” founder Dr. Yamanaka was awarded as Nobel Prize laureate in 2013. For decades, major progresses have been achieved in the stem cell biology field, and more and more evidence showed that skin stem cells are involved in the process of skin repair. Stem/progenitor cells of the epidermis are recognized to play the most essential role in the tissue regeneration of skin. In this review, we first illustrated basic stem cell characteristics and various stem cell subtypes resided in the skin. Second, we provided several literatures to elucidate how stem/progenitor cells collaborate in the process of skin repair with the evidence from animal model studies and in vitro experiments. Third, we also introduced several examples of skin cell products on the pharmaceutic market and the ongoing clinical trials aiming for unmet medical difficulties of skin. Last but not least, we summarized general reviewing concerns and some disputatious issues on dermatological cell products. With this concise review, we hope to provide further beneficial suggestions for the development of more effective and safer dermatological stem/progenitor cell products in the future. |
format | Online Article Text |
id | pubmed-9332639 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Taiwan Food and Drug Administration |
record_format | MEDLINE/PubMed |
spelling | pubmed-93326392022-08-09 Stem cell therapy on skin: Mechanisms, recent advances and drug reviewing issues Chu, Gong-Yau Chen, Yu-Fu Chen, Hsiao-Yun Chan, Ming-Hsiao Gau, Churn-Shiouh Weng, Shih-Ming J Food Drug Anal Review Article Stem cell products and its clinical applications have been widely discussed in recent years, particularly when the Japanese “induced pluripotent stem cells” founder Dr. Yamanaka was awarded as Nobel Prize laureate in 2013. For decades, major progresses have been achieved in the stem cell biology field, and more and more evidence showed that skin stem cells are involved in the process of skin repair. Stem/progenitor cells of the epidermis are recognized to play the most essential role in the tissue regeneration of skin. In this review, we first illustrated basic stem cell characteristics and various stem cell subtypes resided in the skin. Second, we provided several literatures to elucidate how stem/progenitor cells collaborate in the process of skin repair with the evidence from animal model studies and in vitro experiments. Third, we also introduced several examples of skin cell products on the pharmaceutic market and the ongoing clinical trials aiming for unmet medical difficulties of skin. Last but not least, we summarized general reviewing concerns and some disputatious issues on dermatological cell products. With this concise review, we hope to provide further beneficial suggestions for the development of more effective and safer dermatological stem/progenitor cell products in the future. Taiwan Food and Drug Administration 2017-11-11 /pmc/articles/PMC9332639/ /pubmed/29389549 http://dx.doi.org/10.1016/j.jfda.2017.10.004 Text en © 2018 Taiwan Food and Drug Administration https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC-BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) ). |
spellingShingle | Review Article Chu, Gong-Yau Chen, Yu-Fu Chen, Hsiao-Yun Chan, Ming-Hsiao Gau, Churn-Shiouh Weng, Shih-Ming Stem cell therapy on skin: Mechanisms, recent advances and drug reviewing issues |
title | Stem cell therapy on skin: Mechanisms, recent advances and drug reviewing issues |
title_full | Stem cell therapy on skin: Mechanisms, recent advances and drug reviewing issues |
title_fullStr | Stem cell therapy on skin: Mechanisms, recent advances and drug reviewing issues |
title_full_unstemmed | Stem cell therapy on skin: Mechanisms, recent advances and drug reviewing issues |
title_short | Stem cell therapy on skin: Mechanisms, recent advances and drug reviewing issues |
title_sort | stem cell therapy on skin: mechanisms, recent advances and drug reviewing issues |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9332639/ https://www.ncbi.nlm.nih.gov/pubmed/29389549 http://dx.doi.org/10.1016/j.jfda.2017.10.004 |
work_keys_str_mv | AT chugongyau stemcelltherapyonskinmechanismsrecentadvancesanddrugreviewingissues AT chenyufu stemcelltherapyonskinmechanismsrecentadvancesanddrugreviewingissues AT chenhsiaoyun stemcelltherapyonskinmechanismsrecentadvancesanddrugreviewingissues AT chanminghsiao stemcelltherapyonskinmechanismsrecentadvancesanddrugreviewingissues AT gauchurnshiouh stemcelltherapyonskinmechanismsrecentadvancesanddrugreviewingissues AT wengshihming stemcelltherapyonskinmechanismsrecentadvancesanddrugreviewingissues |